ABL1 and alkaline phosphatase measurement: Furthermore, in the current WHO classification, CML-AP is no longer a diagnostic category and growing importance is given to patients at risk for progression based on somatic mutations, TKI resistant BCR::ABL1 mutations and/or additional chromosomal aberrations (ACAs).